Replies to post #17821 on Momenta Pharmaceuticals, Inc. (MNTA)

[jbog]

Just wondering if Mylan flooded the 20mg market. We won't know until the 4th quarter report to see if Sandoz has been sacked the current quarter.

[alternatepatel]

jbog... The recent Teva PR says:

In additional litigation, Teva brought suit against five Abbreviated New Drug Application (ANDA) filers, including Mylan, for infringement of a patent covering a manufacturing process for glatiramer acetate product.

Dew is suggesting that as far as API is manufactured outside of US (e.g. Natco manufactures in India), MYL doesn't need to worry about process patents of TEVA or MNTA. I wonder: Why would TEVA waste their resources if the matter is not worthy of litigation or where the chances of winning are zero?